Takeda aligns with leading rare disease group for calls to action around health equity diagnoses
Takeda isn’t as well-known in rare disease as some other pharma companies, but it’s aiming to take a broader leadership role. Its recent partnership with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
